Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,484 across all filing types
Latest filing 2023-07-11 Annual Report (ESEF)
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
097900BGGW0000048796-20221231-BG-CON.zip
Annual Report (ESEF) Classification · 100% confidence FY 2022
2023-07-11 Bulgarian
EGM 4 August 2023
AGM Information Classification · 19% confidence
2023-07-05 Polish
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 30 June 2023.
Director's Dealing Classification · 100% confidence The document is explicitly titled "Current report: 86/ 03.07.2023 NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". This clearly indicates a report detailing transactions by insiders (directors/managers or closely associated persons). This aligns perfectly with the definition for Director's Dealing (DIRS). The content details the name of the associated person, their position, the issuer, and the details of the transaction involving shares (ISIN № BG11SOSOBT18). This confirms the classification as DIRS.
2023-07-03 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 30 June 2023.
Director's Dealing Classification · 100% confidence The document text explicitly details a 'NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014'. It specifies the 'person discharging managerial responsibilities' (Ognian Donev), the nature of the transaction ('Sell'), the price, volume, and date of the transaction (30.6.2023). This content directly corresponds to the definition of Director's Dealing (insider trades) reports.
2023-07-03 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 30 June 2023.
Director's Dealing Classification · 100% confidence The document text details a transaction involving a 'person discharging managerial responsibilities' (Ognian Donev, Executive director and chairman of the Board of directors of Sopharma AD). It specifies the nature of the transaction as 'Sell' of 'Shares'. This structure—reporting personal share transactions by directors/executives—directly corresponds to the definition of Director's Dealing reports, which are typically mandated under regulations like MAR (Market Abuse Regulation) in the EU. The corresponding code is DIRS.
2023-07-03 English
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 29 June 2023.
Director's Dealing Classification · 100% confidence The document is explicitly titled "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions involving shares by a person closely associated with a manager ('Vesela Stoeva is deputy chairperson of the Board of directors of "Sopharma" AD'). This directly corresponds to the definition of Director's Dealing (insider trades) as per the provided categories. The code for this is DIRS.
2023-06-30 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.